BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30287220)

  • 1. Low density lipoprotein oxidation by ferritin at lysosomal pH.
    Ojo OO; Leake DS
    Chem Phys Lipids; 2018 Dec; 217():51-57. PubMed ID: 30287220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidants inhibit low density lipoprotein oxidation less at lysosomal pH: A possible explanation as to why the clinical trials of antioxidants might have failed.
    Ahmad F; Leake DS
    Chem Phys Lipids; 2018 Jul; 213():13-24. PubMed ID: 29518380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamins E and C do not effectively inhibit low density lipoprotein oxidation by ferritin at lysosomal pH.
    Ojo OO; Leake DS
    Free Radic Res; 2021 May; 55(5):525-534. PubMed ID: 34396869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidation of low-density lipoprotein by iron at lysosomal pH: implications for atherosclerosis.
    Satchell L; Leake DS
    Biochemistry; 2012 May; 51(18):3767-75. PubMed ID: 22493939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vitamin E on low density lipoprotein oxidation at lysosomal pH.
    Alboaklah HKM; Leake DS
    Free Radic Res; 2020 Sep; 54(8-9):574-584. PubMed ID: 32938237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteamine inhibits lysosomal oxidation of low density lipoprotein in human macrophages and reduces atherosclerosis in mice.
    Wen Y; Ahmad F; Mohri Z; Weinberg PD; Leake DS
    Atherosclerosis; 2019 Dec; 291():9-18. PubMed ID: 31629988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lysosomal low-density lipoprotein oxidation by ferritin on macrophage function.
    Ojo OO; Leake DS
    Free Radic Res; 2022; 56(5-6):436-446. PubMed ID: 36217887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal oxidation of LDL alters lysosomal pH, induces senescence, and increases secretion of pro-inflammatory cytokines in human macrophages.
    Ahmad F; Leake DS
    J Lipid Res; 2019 Jan; 60(1):98-110. PubMed ID: 30397186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions?
    Leake DS
    Atherosclerosis; 1997 Mar; 129(2):149-57. PubMed ID: 9105556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron as a catalyst of human low-density lipoprotein oxidation: Critical factors involved in its oxidant properties.
    Lapenna D; Ciofani G; Obletter G
    J Trace Elem Med Biol; 2017 May; 41():111-118. PubMed ID: 28347457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein.
    Lamb DJ; Leake DS
    FEBS Lett; 1994 Sep; 352(1):15-8. PubMed ID: 7925932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromium and human low-density lipoprotein oxidation.
    Lapenna D; Ciofani G
    J Trace Elem Med Biol; 2020 May; 59():126411. PubMed ID: 32058272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low density lipoprotein undergoes oxidation within lysosomes in cells.
    Wen Y; Leake DS
    Circ Res; 2007 May; 100(9):1337-43. PubMed ID: 17446432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human serum, cysteine and histidine inhibit the oxidation of low density lipoprotein less at acidic pH.
    Patterson RA; Leake DS
    FEBS Lett; 1998 Sep; 434(3):317-21. PubMed ID: 9742946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of low density lipoprotein by iron or copper at acidic pH.
    Morgan J; Leake DS
    J Lipid Res; 1995 Dec; 36(12):2504-12. PubMed ID: 8847477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of the antioxidant to pro-oxidant switch in the behavior of dehydroascorbate during LDL oxidation by copper(II) ions.
    Horsley ET; Burkitt MJ; Jones CM; Patterson RA; Harris LK; Moss NJ; del Rio JD; Leake DS
    Arch Biochem Biophys; 2007 Sep; 465(2):303-14. PubMed ID: 17689484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascorbate promotes low density lipoprotein oxidation in the presence of ferritin.
    Dai L; Winyard PG; Zhang Z; Blake DR; Morris CJ
    Biochim Biophys Acta; 1996 Dec; 1304(3):223-8. PubMed ID: 8982268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel cellular defenses against iron and oxidation: ferritin and autophagocytosis preserve lysosomal stability in airway epithelium.
    Persson HL; Nilsson KJ; Brunk UT
    Redox Rep; 2001; 6(1):57-63. PubMed ID: 11333118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein.
    Lynch SM; Campione AL; Moore MK
    Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis.
    Yuan XM; Anders WL; Olsson AG; Brunk UT
    Atherosclerosis; 1996 Jul; 124(1):61-73. PubMed ID: 8800494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.